NewAmsterdam Pharma Co. NV (NAMS)
34.18
+1.19
(+3.61%)
USD |
NASDAQ |
Apr 06, 15:04
NewAmsterdam Pharma Total Liabilities (Quarterly) : 85.85M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| uniQure NV | 626.01M |
| ProQR Therapeutics NV | 74.44M |
| argenx SE | -- |
| Pharming Group NV | 233.34M |
| Pharvaris NV | 35.45M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 769.28M |
| Shareholders Equity (Quarterly) | 683.43M |
| Debt to Equity Ratio | 0.0003 |
| Current Ratio | 7.876 |
| Net Debt Paydown Yield | 0.00% |